A rational strategy to design multiepitope immunogens based on multiple Th lymphocyte epitopes.

Area of Science:

• Immunology
• Vaccinology
• Molecular Biology

Background:

• Developing effective vaccines against HIV requires inducing robust T-helper lymphocyte (HTL) responses.
• Murine models are crucial for evaluating epitope-based vaccine strategies before human trials.
• Understanding immunodominance is key to achieving multispecific immune responses.

Purpose of the Study:

• To evaluate vaccine design strategies for simultaneously inducing multiple HTL responses against HIV epitopes.
• To assess the feasibility of using murine models for epitope-based vaccine development.
• To identify methods for overcoming immunodominance and achieving balanced multispecific responses.

Main Methods:

• Utilized four HLA-DR-restricted HIV-derived HTL epitopes cross-reactive with murine I-A(b) class II molecule.
• Administered immunizations using peptide pools, multiple antigen peptide constructs, and linear polypeptides.
• Introduced GPGPG spacers into constructs and evaluated DNA immunization strategies.

Main Results:

• All four epitopes were immunogenic in H-2(b) mice, validating the murine model.
• A pool of peptides induced responses against all four epitopes, demonstrating balanced multispecificity.
• Linear polypeptides were more efficient than multi-Ag peptide constructs; a junctional epitope hindered immunogenicity, which was restored by a GPGPG spacer.

Conclusions:

• Murine models are feasible for evaluating epitope-based vaccines for human use.
• Balanced multispecific HTL responses can be induced, even in the presence of immunodominance.
• GPGPG spacer constructs offer a flexible approach for polypeptide or DNA immunization to induce HTL responses.